조제 약국 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Compounding Pharmacies Market size is expected to reach USD 31.98 Billion in 2034 from USD 19.75 Billion (2025) growing at a CAGR of 5.5% during 2026-2034.

The global compounding pharmacies market is growing steadily due to increasing demand for personalized medications tailored to individual patient needs. Compounding pharmacies prepare customized formulations when commercially available drugs do not meet specific dosage or ingredient requirements. This practice is particularly important for patients with allergies, pediatric patients, and individuals requiring specialized drug combinations. The rising prevalence of chronic diseases and the growing need for patient-specific treatments are supporting the expansion of this market.

Another factor driving market growth is the increasing focus on personalized medicine and specialty pharmaceuticals. Compounding pharmacies provide customized solutions in areas such as hormone replacement therapy, pain management, dermatology, and veterinary medicine. In addition, technological advancements in pharmaceutical compounding equipment and improved regulatory frameworks are enhancing product safety and quality. Healthcare providers are increasingly collaborating with compounding pharmacies to deliver tailored treatment solutions.

In the coming years, the compounding pharmacies market is expected to expand as personalized healthcare becomes more prominent. Rising investments in pharmaceutical research and development and growing awareness among healthcare professionals about customized medications will support market growth. Furthermore, advancements in compounding technologies and regulatory oversight are likely to enhance the credibility and adoption of compounded pharmaceutical products worldwide.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Therapeutic Area

• Hormone Replacement Therapy
• Pain Management
• Specialty Drugs
• Dermatology
• Nutritional Supplements
• Others

By Age Cohort

• Pediatric
• Adult
• Geriatric

By Compounding Type

• Pharmaceutical Ingredient Alteration (PIA)
• Currently Unavailable Pharmaceutical Manufacturing (CUPM)
• Pharmaceutical Dosage Alteration (PDA)
• Others

By Sterility

• Sterile
• Non-sterile

COMPANIES PROFILED

• Walgreen Co, JL Diekman and AQ Touchard Fresh Therapeutics Compounding Pharmacy, Fagron, Albertsons Companies, The London Specialist Pharmacy Ltd Specialist Pharmacy, Galenic Laboratories Limited Roseway Labs, Aurora Compounding, MEDS Pharmacy, Apollo Clinical Pharmacy, Formul8, Fusion Apothecary
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL COMPOUNDING PHARMACIES MARKET: BY THERAPEUTIC AREA 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Therapeutic Area
• 4.2. Hormone Replacement Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Pain Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Specialty Drugs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Dermatology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Nutritional Supplements Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL COMPOUNDING PHARMACIES MARKET: BY AGE COHORT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Age Cohort
• 5.2. Pediatric Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Adult Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Geriatric Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL COMPOUNDING PHARMACIES MARKET: BY COMPOUNDING TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Compounding Type
• 6.2. Pharmaceutical Ingredient Alteration (PIA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Currently Unavailable Pharmaceutical Manufacturing (CUPM) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Pharmaceutical Dosage Alteration (PDA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL COMPOUNDING PHARMACIES MARKET: BY STERILITY 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Sterility
• 7.2. Sterile Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Non-sterile Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL COMPOUNDING PHARMACIES MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Therapeutic Area
  • 8.2.2 By Age Cohort
  • 8.2.3 By Compounding Type
  • 8.2.4 By Sterility
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Therapeutic Area
  • 8.3.2 By Age Cohort
  • 8.3.3 By Compounding Type
  • 8.3.4 By Sterility
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Therapeutic Area
  • 8.4.2 By Age Cohort
  • 8.4.3 By Compounding Type
  • 8.4.4 By Sterility
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Therapeutic Area
  • 8.5.2 By Age Cohort
  • 8.5.3 By Compounding Type
  • 8.5.4 By Sterility
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Therapeutic Area
  • 8.6.2 By Age Cohort
  • 8.6.3 By Compounding Type
  • 8.6.4 By Sterility
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL COMPOUNDING PHARMACIES INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Walgreen Co
  • 10.2.2 JL Diekman And AQ Touchard (Fresh Therapeutics Compounding Pharmacy)
  • 10.2.3 Fagron
  • 10.2.4 Albertsons Companies
  • 10.2.5 The London Specialist Pharmacy Ltd (Specialist Pharmacy)
  • 10.2.6 Galenic Laboratories Limited (Roseway Labs)
  • 10.2.7 Aurora Compounding
  • 10.2.8 MEDS Pharmacy
  • 10.2.9 Apollo Clinical Pharmacy
  • 10.2.10 Formul8
  • 10.2.11 Fusion Apothecary